Published On: Mar 2026
As per the latest market research by Business Market Insights (BMI), the research report "Supraglottic Devices Market Size and Forecast (2025–2033)" forecasts how the market is set to surge 39.6% by 2033. The global supraglottic devices market is driven by increasing adoption of minimally invasive airway management techniques and the rising number of surgical and emergency procedures requiring effective ventilation support. Growing preference for rapid, non-invasive airway access is accelerating utilization. Expanding applications in ambulatory and prehospital care, along with continuous innovations in device design and improved sealing technology, are further supporting sustained market growth.
The report forecasts the market to expand from US$ 2,083.8 million in 2025 to US$ 2,908.8 million by 2033, registering a robust CAGR of 4.3% over the 2026–2033 period.
The global supraglottic devices market is a key segment of airway management within anesthesiology and emergency medicine, providing essential tools for maintaining ventilation during surgical procedures, emergency resuscitation, and critical care settings. These devices are widely used in hospitals, ambulatory surgical centers, and prehospital environments, particularly for patients undergoing elective surgeries, those with difficult airways, and individuals experiencing respiratory compromise. Market growth is driven by the rising volume of surgical procedures, increasing prevalence of respiratory and cardiovascular conditions, and a growing aging population that is more susceptible to airway management complications. Technological advancements, including second-generation supraglottic airways with improved sealing mechanisms, integrated gastric access channels, and the increasing shift toward single-use disposable designs, have enhanced safety, efficiency, and infection control. Additionally, expanding adoption in emergency medical services, increasing penetration in emerging healthcare markets, and the global expansion of ambulatory care infrastructure are supporting broader clinical utilization and market expansion.
The supraglottic devices market is projected to grow from US$ 2,083.8 million in 2025 to US$ 2,908.8 million by 2033, registering a compound annual growth rate (CAGR) of 4.3% between 2026 and 2033.
The global supraglottic devices market is driven by increasing adoption of minimally invasive airway management techniques and the rising number of surgical and emergency procedures requiring effective ventilation support. Growing preference for rapid, non-invasive airway access is accelerating utilization. Expanding applications in ambulatory and prehospital care, along with continuous innovations in device design and improved sealing technology, are further supporting sustained market growth.
The increasing global prevalence of respiratory diseases is a key driver of the supraglottic devices market. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, obstructive sleep apnea (OSA), and acute respiratory failure are rising due to aging populations, urban air pollution, and lifestyle-related risk factors including smoking and obesity. Elderly patients, who often present with reduced pulmonary reserve and multiple comorbidities, frequently require airway support during anesthesia and emergency interventions, directly increasing the adoption of supraglottic airway devices (SADs) such as laryngeal mask airways. Improved diagnostic capabilities, including advanced pulmonary function testing and sleep studies, have enabled earlier detection of airway-related disorders, expanding the patient base requiring airway management. The growing recognition of OSA, in particular, has increased use of supraglottic devices in perioperative care and sedation procedures. Technological advancements are enhancing device safety and performance. Modern supraglottic devices offer improved cuff sealing, higher leak pressures, and better anatomical conformity, reducing aspiration risk and improving ventilation efficiency. Clinician familiarity with these devices has also increased due to expanded anesthesia training and standardized airway management protocols. Ongoing innovation, including second-generation supraglottic devices with gastric access channels and disposable variants, is further supporting adoption. Globally, rising healthcare investments and expanding critical care infrastructure are expected to drive sustained long-term demand across emergency, surgical, and intensive care settings.
The rapid global shift toward minimally invasive surgical techniques is significantly boosting demand for supraglottic devices. Procedures such as laparoscopic, robotic-assisted, and endoscopic surgeries are increasingly preferred due to reduced tissue trauma, lower complication rates, and faster postoperative recovery. Supraglottic airway devices are widely used in these settings as they provide effective airway management without the need for invasive tracheal intubation in selected patient populations. These devices offer several clinical advantages, including reduced hemodynamic response during insertion, lower incidence of sore throat, and decreased airway trauma compared to traditional endotracheal tubes. As a result, they are increasingly utilized in short-duration surgeries, outpatient procedures, and ambulatory surgical centers where rapid induction and emergence from anesthesia are critical. The suitability of supraglottic devices for high-risk patients, including obese, elderly, and difficult airway cases, has further expanded their clinical utility. Second-generation devices with improved sealing pressures and gastric drainage channels enhance patient safety by reducing aspiration risk during positive pressure ventilation. Technological advancements such as disposable supraglottic airways, integrated bite blocks, and enhanced ergonomic designs are improving infection control and procedural efficiency. Expanding surgical volumes in emerging markets across Asia-Pacific and Latin America, combined with strong adoption in developed healthcare systems, is accelerating global market penetration. Enhanced recovery after surgery (ERAS) protocols are further reinforcing the preference for supraglottic devices in modern perioperative care pathways.
North America dominates the supraglottic airway devices market, driven by a high concentration of ambulatory surgical centers (ASCs) where these devices are widely used as first-line airway tools in short-duration procedures. The region also sees strong utilization in emergency medical services (EMS), where rapid airway stabilization is critical in trauma and cardiac arrest cases. A key differentiator is the routine incorporation of supraglottic devices in difficult airway algorithms recommended by anesthesiology societies, supporting consistent clinical uptake. Additionally, high adoption of single-use devices due to infection-control protocols and strong procurement systems in hospital networks reinforces demand. Continuous product innovation, including gel-based and anatomically pre-shaped devices, further accelerates replacement cycles.
Europe holds a strong position due to its standardized anesthesia protocols and widespread use of supraglottic devices in day-case surgeries, particularly in orthopedic and gynecological procedures where fast recovery and low complication rates are prioritized. Several European countries have integrated these devices into national airway management guidelines for both routine and rescue ventilation scenarios. The region also demonstrates high adoption in military and pre-hospital care systems, where portability and ease of insertion are critical. Growing preference for environmentally conscious healthcare procurement has encouraged development of reusable and low-waste device variants, influencing purchasing patterns across public hospitals and teaching institutions.
Asia Pacific is experiencing the most rapid expansion, largely driven by increasing penetration of supraglottic devices in tier-2 and tier-3 hospitals where they are replacing more complex endotracheal intubation in low-risk surgeries. A notable growth factor is the rising number of anesthesia-led short surgical camps and mobile surgical units, particularly in rural healthcare outreach programs. Training initiatives by regional anesthesiology associations are also expanding clinical familiarity among junior practitioners. In addition, domestic manufacturers are introducing cost-optimized devices tailored for high-volume government tenders, significantly improving accessibility. The growing use of these devices in obstetric anesthesia and pediatric care is further widening their clinical footprint across the region.
The supraglottic devices market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:
Second-generation supraglottic airway devices, third-generation supraglottic airway devices with gastric drainage channels, single-use supraglottic airway devices, reusable laryngeal mask airways (LMAs), preloaded and rapid-insertion supraglottic rescue devices, video-assisted supraglottic airway devices, cuffless and low-pressure cuff supraglottic devices, intubating laryngeal mask airways (ILMAs), pediatric supraglottic airway devices, anti-leak and high-seal pressure supraglottic airway systems
The global supraglottic airway devices market is witnessing steady growth, driven by the rising burden of respiratory emergencies, increasing surgical procedures, and growing preference for minimally invasive airway management techniques. Continuous advancements in device design, including second- and third-generation supraglottic devices with improved sealing pressure, gastric access, and enhanced patient safety features, are significantly boosting clinical adoption across anesthesia, emergency medicine, and critical care settings. North America and Europe continue to represent mature markets with high adoption rates supported by established clinical protocols, while Asia-Pacific is emerging as the fastest-growing region due to expanding healthcare infrastructure and increasing surgical volumes. Latin America and the Middle East & Africa are gradually progressing, supported by improving access to advanced medical technologies. Favorable airway management guidelines and growing emphasis on patient safety are further strengthening demand.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
